Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A7CE
|
|||
| Drug Name |
PMID28766366-Compound-Scheme15-1
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
LYTIX BIOPHARMA AS
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H10N2O2S
|
|||
| Canonical SMILES |
CC(=O)NC1=NC2=C(S1)C=CC(=C2)OC
|
|||
| InChI |
1S/C10H10N2O2S/c1-6(13)11-10-12-8-5-7(14-2)3-4-9(8)15-10/h3-5H,1-2H3,(H,11,12,13)
|
|||
| InChIKey |
ZKNFVQNHIHCHEW-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.Expert Opin Ther Pat. 2017 Nov;27(11):1183-1199. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.